Marine-derived Pharmaceuticals Market

Marine-derived Pharmaceuticals Market is Focusing on the Key Segments, which are Drug Type, Source, Sales Channel and Region - Global Market Insights 2023 to 2033

Analysis of Marine-derived Pharmaceuticals Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Marine-derived Pharmaceuticals Market Outlook (2023 to 2033)

The market for pharmaceuticals derived from marine sources is anticipated to grow from US$ 4,131.3 million in 2023 to US$ 9,083.1 million in 2033. Global sales of pharmaceuticals derived from marine sources are predicted to increase at a CAGR of 8.2% over the ensuing ten years (2023 - 2033).


Key Insights

Estimated Global Marine-derived Pharmaceuticals Market Size (2023E)

US$ 4,131.3 million

Projected Marine-derived Pharmaceuticals Market Value (2033F)

US$ 9,083.1 million

Value-based CAGR (2023 to 2033)


Top 3 Countrie’s Value

US$ 1,499.7 million

Top 3 Countrie’s Share


Key Trends Listed by Fact.MR :

  • Use of marine ingredients to manufacture multiple products across various industries, cosmetics, and food and beverage due to their medicinal properties have caught the attention of the medical community
  • Technological advancements in the field of medicine have helped the industry tap into multiple alternatives such as sourcing ingredients from marine sources that provide greater promise in the long run
  • There is a growing inclination and interest toward the potential of marine microbes in the field of medicine to produce novel drugs and supplements
  • Several marine-derived by-products like Ara-A, didemnins, Patellazole B have antiviral properties and can be used in the field of medicine to formulate drugs, medicines, and dietary supplements
  • Marine-derived pharmaceuticals are used as sources of chemical diversity in drug discovery programs
  • Marine biotechnology is an emerging field and plays a fundamental role in the formulation of new pharmaceutical products
  • Pharmaceutical companies are increasingly reviewing multiple marine sources in search of active ingredients
  • Today, with the use of multiple modern tools in the field of molecular biology and advanced technology the potential of marine by-products can be harnessed to formulate Marine-derived pharmaceuticals
  • Marine organisms provide a vast reservoir of natural and original molecules that can be used to treat life-threatening diseases like cancer and other disorders
  • Marine-derived chemicals have the potential to act as key alternatives to exhaustible resources in the pharmaceutical industry as many marine by-products hold anti-inflammatory, anticancer, antiviral, and antibacterial properties
  • Marine compounds that can be farmed or grown in order to yield valuable compounds hold potential in the pharmaceutical and medical industry

One of the most abundant sources of valuable chemical compounds is marine sponges. There are ~15,000 natural Marine-derived products that have the potential to be used in the pharmaceutical and medical industry and ~30% of them are isolated from marine sponges. Sponges produce a wider variety of chemical structures than any other known species of marine organisms.

Additionally, marine sponges is a specie that is available in all water bodies. There are species of marine sponges like Disidea avara that inhabit immunodeficiency virus and have therapeutic properties. Bryozoans, which is known best for their potential to be used as an anti-cancer drug. Other products like mollusks, cnidarians, and algae also hold potential.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

2018 to 2022 Global Marine-derived Pharmaceuticals Sales Outlook Compared to Demand Forecast from 2023 to 2033

According to the Fact.MR analysis, global Marine-derived Pharmaceuticals sales grew at a CAGR of 7.5% from 2018 to 2022. For the next ten years, the worldwide market for Marine-derived Pharmaceuticals is forecast to progress at 8.2% CAGR.

In recent years there has been an increase in the inclination of the medical industry to look for alternatives to conventional sources of chemical compounds that can be used to formulate and manufacture drugs and medications that cater to a specific deficiency. There has been a growing interest in the potential of ocean bodies to be the home of multiple bioactive compound alternatives. To harness the potential of marine biotechnology in pharmaceutical and medical science developing an understanding of genetics is necessary.

Marine by-products and marine sources should be used to formulate drugs and medications for tropical infections and chronic diseases that modern-day medications and supplements are not able to cure. Additionally, due to the abundance of marine resources, the easy availability of raw materials will help manufacturers lower the price of medications which will help in the eradication of epidemics from the lower middle class and lower sections of society.

Attention should be paid to the development of pharmaceuticals from marine sources considering the advances made in the field of biotechnology and discoveries made in terms of novel marine compounds that can be used to formulate effective and natural drugs and medicines. Marine sources have shown potential in the treatment of cancer, infectious diseases, and disorders.

Adjacent Markets Overview :

Dietary Supplements :

Attributes Dietary Supplements

CAGR (2023 to 2033)


Market Value (2033)

~US$ 140,005.7 million

Growth Factor

Preventive health is better than treatment. Modern-day consumers are more cautious about their health and wellness and hence are more inclined towards regular consumption of supplements to meet their daily nutritional requirements.


Increasing lifestyle diseases among consumers due to hectic lifestyle patterns have prompted consumers to take preventive measures to lead a healthy life. This provides manufacturers with the ability to formulate supplements that are easy to consume on a daily basis and have lesser side effects.

Key Trends

Clean Label Trend Gaining Traction - According to the Food Insider Journal, 75% of consumers are willing to pay extra for clean-label ingredients.

Oral Clinical Nutrition Supplement :

Attributes Oral Clinical Nutrition Supplement

CAGR (2023 to 2033)


Market Value (2033)

~US$ 17,450.2 million

Growth Factor

There is an increase in the awareness of oral clinical nutritional supplements in youngsters as oral clinical nutrition supplements provide nutrients, including protein and energy.


The rise in diseases like malnutrition, diabetes, and other vitamin and mineral deficiencies have given rise to the need for oral supplements to be taken on a daily basis.

Key Trends

Increase in the attention towards personal health and a nutritionally balanced diet, and increased healthcare spending.

Plant-based iron Supplements Market :

Attributes Plant-based iron Supplements Market

CAGR (2023 to 2033)


Market Value (2033)

~US$ 355.6 million

Growth Factor

Demand for organic products in the global market and support by local companies for the development of natural products is expected to drive the growth of the market.


Government support towards plant-based alternatives has added to the demand for plant-based iron supplements in the market. Governments of various regions are also supporting the formulation of plant-based alter.

Key Trends

There is a rise in demand for supplements that cater to a specific deficiency like iron deficiency, vitamin B12 deficiency, and more and hence there is a growing trend of nutrition-specific supplements in the market.

Country-wise Insights :

North America - CAGR

Country CAGR (%)
United States 7.2%

Europe - CAGR

Country CAGR (%)
United Kingdom 5.6%

Asia Pacific - CAGR

Country CAGR (%)
China 5.6%
India 6.5%
Japan 6.8%

North America - BPS Analysis

Country BPS Analysis
United States 90

Europe - BPS Analysis

Country BPS Analysis
United Kingdom -50

Asia Pacific - BPS Analysis

Country BPS Analysis
China 60
India 180
Japan -20

North America - Market Value (2033)

Country Market Value (2033)
United States US$ 1,925.6 million

Europe - Market Value (2033)

Country Market Value (2033)
United Kingdom US$ 890.2 million

Asia Pacific - Market Value (2033)

Country Market Value (2033)
China US$ 572.2 million
India US$ 499.6 million
Japan US$ 227.1 million

China is committed to the marine-derived pharmaceutical industry and its efforts to harness the potential of marine resources for drug discovery and development.

As per Fact.MR, China’s Marine-derived Pharmaceuticals market is expected to reach a valuation of around US$ 599.5 million by 2033.

China has a vast coastline covering ~14,500 kilometers and is home to a diverse range of marine habitats and ecosystems. Its vast biodiversity includes various species of marine organisms like algae, microorganisms, and invertebrates that possess a bioactive compounds that hold a strong potential in the pharmaceutical industry.

China’s regulatory framework for marine-derived pharmaceuticals has evolved with innovation and ensures safety and quality. The China Food and Drug Administration (CFDA) regulates the pharmaceuticals in the country. It has set specific guidelines for marine-derived drugs that ensure compliance and safety standards.

China is also known to actively collaborate with other countries in international marine research projects. In 2022, there were 15 marine-derived drugs approved by the FDA of which one was approved in China and the rest in Australia.

Demand Outlook for the Marine-derived Pharmaceuticals in India Market

India has immense potential due its rich marine biodiversity and is investing heavily in research related to the potential of Marine-derived sources in pharmaceutical and medical industry

Marine-derived Pharmaceuticals demand in India is anticipated to rise at a steady CAGR of 6.5% during the forecast period from 2023 to 2033 and is expected to reach a market valuation of US$ 499.6 Mn by 2033.

India has a huge market for animal feed. Marine algae such as seaweeds hold a lot of potential as ingredients in animal feed. Algae are rich in nutrients like proteins, vitamins and minerals and are also a good source of bioactive compounds which are very useful in the pharmaceutical sector. Algae are also easy to be cultivated and farmed in coastal regions or offshore waters providing a sustainable and renewable source of feed alternatives

In India, manufacturers have increased their focus on sustainable sourcing of raw materials. Alternatives like seaweed and microalgae hold potential. Additionally, making use of by-products formed in the fish processing industry also help in minimizing the pollution and degradation of water bodies.

Which is the Most Sought-after Drug Type in the Market?

Demand in the Market to Remain High for Fish Meal Marine-derived Pharmaceuticals

One of the most valuable and sought-after drug types that can be derived from marine sources is anti-cancer drugs. Cancer is a major global health concern today and there is a continuous need for effective treatment of the same. Marine organisms are a valuable source of bioactive compounds which hold anti-cancer properties. Some marine-derived compounds have specific properties that inhibit tumour growth and recurrence.

Marine sources are also known to have anti-inflammatory, neuroprotective properties as a result of which they hold potential in the medical and pharmaceutical industry. The marine-derived pharmaceutical industry is continuously evolving with increasing investment in research and development in exploring the therapeutic potential of marine resources.

Why is Demand for Marine Sponges in Marine-derived Pharmaceuticals Rising Globally?

Marine sponges are a good source of bioactive compounds, including alkaloids, peptides, terpenoids, polyketides, and sterols.

Marine sponges are a rich source of bioactive compounds with diverse chemical structures and potent pharmacological activities. Many compounds derived from marine sponges have a wide range of pharmacological activities, such as anticancer, antiviral, neuroprotective, and antimicrobial. These diverse activities make marine sponge-derived compounds a valuable source for the pharmaceutical industry with a wide range of therapeutic applications.

Moreover, marine sponges can be farmed sustainably, ensuring minimal impact on the marine ecosystem which makes them an environmentally friendly source of bioactive compounds.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Competitive Landscape :

The competitive landscape of Marine-derived Pharmaceuticals is dynamic and constantly evolving as the demand for sustainable and cost-effective options continues to grow. Several factors influence the competitiveness of Marine-derived Pharmaceuticals, and nutritional value, including availability, cost, and regulatory considerations.

Scope of the Report :



Market Size Value in 2023

US$ 4,131.3 million

Market Forecast Value in 2033

US$ 9,083.1 million

Anticipated Growth Rate (2023 to 2033)

8.2% CAGR

Forecast Period

2023 to 2033

Historical Data Available for

2018 to 2022

Market Analysis

  • Volume (MT)
  • Value (US$ Million)

Key Regions Covered

  • Latin America
  • North America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Countries Covered

  • Canada
  • United States
  • Mexico
  • Brazil
  • Chile
  • Peru
  • Argentina
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Netherlands
  • Belgium
  • Nordic
  • Russia
  • Poland
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Singapore
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • Central Africa
  • Others

Key Market Segments Covered

  • Drug Type
  • Source
  • Sales Channel

Key Companies Profiled

  • Pfizer Inc.
  • TerSera Therapeutics LLC.
  • Janssen Products, LP
  • Eisai Inc.
  • Biotium
  • PharmaMar
  • Zeltia ZEL.MC
  • High Liner Foods Inc.
  • GFR Pharma
  • Amway Corp.
  • General Mills Inc
  • Standard Functional Foods Group Inc.
  • Abbott Laboratories
  • Roquette Kloetze
  • Rizhao Jiejing Ocean Biotechnology Development Co., LTD
  • AlgaNovo International Co., Ltd
  • Yigeda Bio-Technology Co., Ltd
  • EID Parry
  • BASF (Cognis Australia, Betatene/BASF (DE)
  • Natural Beta Technologies
  • Cyanotech
  • Mera Pharma
  • BioReal

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Marine-derived Pharmaceuticals Market by Category :

  • By Drug Type :

    • Antibacterial
    • Anti-inflammatory
    • Neuroprotective
    • Antiviral agent
    • Anticancer
    • Analgesic
    • Antimicrobial
  • By Source :

    • Algae
    • Tunicate/Ascidiacea
    • Marine Sponges
    • Actinomyces
    • Mollusc
    • Bryoza
    • Shark Cartilage
    • Marine Fungi
    • Soft Corals
  • By Sales Channel :

    • Prescription Based
    • Over the Counter
    • Drug Stores
    • Pharmacies
    • Retail Stores
    • Online Merchandizers
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia
    • Oceania
    • Middle East & Africa

- FAQs -

How big is the global Marine-derived Pharmaceuticals industry?

The Marine-derived Pharmaceuticals market is estimated to reach a valuation of about US$ 4,131.3 million in 2023.

How big is the United States Marine-derived Pharmaceuticals industry?

The Marine-derived Pharmaceuticals market is estimated to reach a valuation of about US$ 838.7 million in 2023.

What is the growth projection for the worldwide Marine-derived Pharmaceuticals industry by 2033?

The global Marine-derived Pharmaceuticals market value is projected to reach US$ 9,083.1 million by 2033.

At what rate is global demand for Marine-derived Pharmaceuticals expected to increase from 2023 to 2033?

Global Marine-derived Pharmaceuticals demand is expected to increase at a CAGR of around 8.2% through 2033.

What Marine source is in high demand as an ideal source of Marine-derived pharmaceutical products?

One of the most sought-after sources in marine-derived pharmaceuticals is marine sponges. Marine sponges have been recognized as a rich source of bioactive compounds with diverse chemical structures and potent pharmacological activities.

What was the historical CAGR for the Marine-derived Pharmaceuticals Market?

Global demand for Marine-derived Pharmaceuticals registered a CAGR of 7.5% historically, from 2018 to 2022.

What components of Shark Cartilage make it an ideal source for the Marine-derived Pharmaceuticals Market?

Shark cartilage is primarily composed of proteins, glycosaminoglycans (such as chondroitin sulfate), and calcium salts. It also contains other bioactive components, including small peptides, lectins, and growth factors, which makes it an ideal source for

- Also of Interest -

Marine Collagen Ingredients Market

Marine Collagen Ingredients Market Analysis By Source (Fish, Squid, Jellyfish), By Type, By Form, By Application and By Region - Global Market Insights 2023 to 2033

Marine Algae Market

Marine Algae Market Analysis on the Basis of Type (Brown Algae, Green Algae, Blue-Green Algae, Red Algae), By Application and Region - Global Market Insights 2023 to 2033

Marine Algae Polysaccharides Market

Marine Algae Polysaccharides Market on the Basis of Source (Brown Algae, Green Algae, Red Algae), By Application and By Region - Global Market Insights 2023 to 2033

Marine Collagen Powder Market

Marine Collagen Powder Market By Source (Fish, Shellfish peptides, Seaweed), By Nature and By Region - Global Market Insights 2023 to 2033

Marine-derived Pharmaceuticals Market

Schedule a Call